Browse by region

World Map Middle East Africa South Asia Asia/Pacific Europe South America North America

FDA Accepts BLA for Inhalational Anthrax Countermeasure

(Global Biodefense) Anthim (obiltoxaximab) is for the treatment and prevention of inhalational anthrax, and is a candidate for future acquisition into the Strategic National Stockpile, the U.S. government’s repository of critical medical supplies for biowarfare preparedness.  Anthim has been developed under Fast-Track status and Orphan Drug Designation by the FDA.

South Korea MERS death toll rises to 20

(CNN) The World Health Organization said Tuesday that the number of new cases “appears to be declining” – indicating that the outbreak could be slowing down. But it also warned that “all outbreaks are unpredictable…especially for a comparatively new disease like MERS” where many facets of the virus are not well  Read More »

What you should know about MERS, the mystery disease that has South Korea on edge

(Washington Post) The spread of MERS, which has infected 126 people since the outbreak began last month, seems to have leveled off, and South Korean public health officials are urging calm. Still, Koreans remain wary of this new and little-understood illness. MERS first appeared in humans in 2012, and three years later scientists and public health officials are  Read More »

The Ebola Review, Part II

(Foreign Policy) The G-7 Summit in Germany convening June 7 to June 8 will focus on the epidemic threat agenda, framed both as biosecurity and health system strengthening…  German Chancellor Angela Merkel said: “We need some kind of global disaster response plan. And the World Health Organization must play a key part in  Read More »

The Ebola Review, Part I

(Foreign Policy) The G-7 nations will commence their annual summit on June 7 in Germany, and the host, Chancellor Angela Merkel, has put the Ebola epidemic and its implications for global biosecurity at the top of the agenda.